Protara Therapeutics, Inc.
TARA
Revenue
2.95M
▲2.95M∞%
-Assets
101.65M
▲33.51M▲49.19%
3 Months ChangeLiabilities
9.60M
▼-131.00k▼-1.35%
3 Months ChangeFree Cash Flow
-12.89M
▼-1.92M▼-17.52%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-06
Form 10-Q
ID: 0001213900-24-065380
2024-08-06
Form 8-K
ID: 0001213900-24-065378
2024-06-10
Form 8-K
ID: 0001213900-24-051210
2024-05-02
Form 10-Q
ID: 0001213900-24-038757
2024-05-02
Form 8-K
ID: 0001213900-24-038756
2024-04-05
Form 8-K
ID: 0001213900-24-030623
2024-03-18
Form 8-K
ID: 0001213900-24-023589
2024-03-13
Form 8-K
ID: 0001213900-24-021981
2023-11-03
Form 10-Q
ID: 0001213900-23-083013
2023-11-03
Form 8-K
ID: 0001213900-23-083011